Trident II Tritanium Acetabular Shell Outcomes Study
NCT: NCT02999009 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of this study is to review the performance and success rate of an FDA approved cementless hip replacement part called the Trident II Tritanium Acetabular Shell. The study will specifically look at the need to revise the hip replacement after 5 years. This will be compared to how much this happens in patients who have hip replacement with similar cementless acetabular shells.
Frequently Asked Questions
What is Trident II Tritanium Acetabular Shell Outcomes Study?
Trident II Tritanium Acetabular Shell Outcomes Study is a clinical trial registered under NCT02999009. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT02999009?
The current status of NCT02999009 (Trident II Tritanium Acetabular Shell Outcomes Study) is: ACTIVE_NOT_RECRUITING.
When did Trident II Tritanium Acetabular Shell Outcomes Study start?
Trident II Tritanium Acetabular Shell Outcomes Study started on 2017-01-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.